Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
Mar. 31, 2023 |
Mar. 31, 2022 |
Jun. 30, 2022 |
Jun. 30, 2021 |
|
| REVENUE | ||||||
| Revenue | ||||||
| OPERATING EXPENSES | ||||||
| Administration expenses | 311,824 | 443,629 | 1,302,576 | 1,221,533 | 1,706,452 | 1,553,075 |
| Occupancy expenses - related party | 8,365 | 8,157 | 22,244 | 22,443 | 28,366 | 28,112 |
| Research and development | 66,020 | 50,395 | 242,223 | 147,702 | 256,052 | 230,956 |
| TOTAL OPERATING EXPENSES | 386,209 | 502,181 | 1,567,043 | 1,391,678 | 1,990,870 | 1,812,143 |
| LOSS FROM OPERATIONS | (386,209) | (502,181) | (1,567,043) | (1,391,678) | (1,990,870) | (1,812,143) |
| OTHER INCOME (EXPENSE) | ||||||
| Interest expense | (157,208) | (167,375) | (418,579) | (455,133) | (568,798) | (449,457) |
| Interest income | 8 | 27 | 5,613 | 1 | ||
| Change in fair value of derivative liabilities | (238,367) | 165,365 | (110,859) | (2,392) | (99,111) | (8,186) |
| Gain from settlement of accounts payable | 17,499 | |||||
| Gain from settlement of debt, net | 49,319 | |||||
| Gain on extinguishment of debt, net | (10,724) | 32,186 | (17,503) | 50,607 | ||
| Foreign currency transaction gain (loss) | (19,025) | 41,717 | 3,210 | 40,631 | (42,395) | 30,497 |
| TOTAL OTHER EXPENSE, NET | (425,316) | 39,707 | (476,516) | (416,894) | (722,194) | (327,219) |
| LOSS BEFORE TAXES | (811,525) | (462,474) | (2,043,559) | (1,808,572) | (2,713,064) | (2,139,362) |
| Tax benefit | 1,716 | (213) | 131,037 | 55,250 | 54,977 | 113,415 |
| NET LOSS | (809,809) | (462,687) | (1,912,522) | (1,753,322) | (2,658,087) | (2,025,947) |
| Deemed Dividend | (237,389) | (408,557) | (445,631) | (700,340) | (391,749) | |
| NET LOSS AVAILABLE TO COMMON STOCKHOLDERS | $ (809,809) | $ (700,076) | $ (2,321,079) | $ (2,198,953) | $ (3,358,427) | $ (2,417,696) |
| BASIC AND DILUTED NET LOSS PER SHARE AVAILABLE TO COMMON STOCKHOLDERS | $ (0.42) | $ (10.55) | $ (2.08) | $ (46.23) | $ (49.23) | $ (797.23) |
| BASIC AND DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING | 1,924,074 | 66,354 | 1,115,848 | 47,561 | 68,219 | 3,033 |
| NET LOSS AVAILABLE TO COMMON STOCKHOLDERS | $ (809,809) | $ (700,076) | $ (2,321,079) | $ (2,198,953) | $ (3,358,427) | $ (2,417,696) |
| OTHER COMPREHENSIVE INCOME (LOSS) | ||||||
| Unrealized foreign currency translation gain (loss) | 40,614 | (55,096) | 59,198 | 1,400 | 149,345 | (182,467) |
| TOTAL OTHER COMPREHENSIVE INCOME (LOSS) | 40,614 | (55,096) | 59,198 | 1,400 | 149,345 | (182,467) |
| TOTAL COMPREHENSIVE LOSS | $ (769,195) | $ (755,172) | $ (2,261,881) | $ (2,197,553) | $ (3,209,082) | $ (2,600,163) |
| X | ||||||||||
- Definition Gain from settlement of accounts payable. No definition available.
|
| X | ||||||||||
- Definition Gain from settlement of debt net. No definition available.
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest income earned from interest bearing assets classified as other. No definition available.
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of net occupancy expense that may include items, such as depreciation of facilities and equipment, lease expenses, property taxes and property and casualty insurance expense. Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of other comprehensive income (loss) attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|